{"id":714440,"date":"2022-11-22T16:38:21","date_gmt":"2022-11-22T21:38:21","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\/"},"modified":"2022-11-22T16:38:21","modified_gmt":"2022-11-22T21:38:21","slug":"apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\/","title":{"rendered":"Apellis Pharmaceuticals to Present at Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">WALTHAM, Mass., Nov.  22, 2022  (GLOBE NEWSWIRE) &#8212; \u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Je4TSMDJ43hGno2aE68auDhdfZL2A25YK7fhKWMS7bWKx7txIDdh4BCNKl3A8o_fruXb46hnkKaG7tdY2L4Gkxt5G6ceXrBfMuKKHrjYDYqZyxxqz6aO-KwPBGkCyKLS1NjdN5EmpE0A9p4w5eA2RtNedXSLxFkTY8EiVpxx4uVGjm6OnolWbVdLg8snoF5EbU6MN4Mu1QBQcZlrTX4weQdWoX8xJinOO4mEzhM3HNjumseE3O8yR1qXUMkwi-inMlRmxEK4WgoNXifU6q_7ncVL2xzLecoAmImFsCQ9Dbo4rYSnPFZT5liAyE3fQFsmVcTy1gNMS21l2ujXpjsjPBj2_hVBN8zgj5icJpGynPgGUfwDd_EZ9pKN1EVaKh_vAv-J1GF982lbPLsX8Cc97w4lQtYTLARhbozjGmYRgptxrz_Pz-UK_uFUpU_c9k9UNovq8bQm1WEK0K4YjsWwaAR8caX_RBAB-YP7v5iqddY=\" rel=\"nofollow noopener\" target=\"_blank\"><u>Apellis Pharmaceuticals<\/u><\/a>,\u00a0Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company will participate in the following investor conferences:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-top:12pt;margin-bottom:7.5pt\">\n          <strong>5<\/strong><br \/>\n          <sup><br \/>\n            <strong>th<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Annual Evercore ISI HealthCONx Conference:<\/strong> Fireside chat on Tuesday, November 29, 2022, at 8:25 a.m. ET.<\/li>\n<li style=\"margin-top:12pt;margin-bottom:7.5pt\">\n          <strong>Bank of America 2022 Virtual Biotech SMID Cap Conference:<\/strong> Fireside chat on Wednesday, December 7, 2022, at 9:40 a.m. ET.<\/li>\n<\/ul>\n<p>Each conference event will be available via a live webcast from the \u201cEvents and Presentations\u201d page of the \u201cInvestors and Media\u201d section of the company\u2019s\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KsM3v9WeTNB55Q2LlBD491PKV_NuaQCEBy3_udr3LGvvgVTadmdW81ILJv7x7S8TdmyAet8XW86e92ORSHGT9w==\" rel=\"nofollow noopener\" target=\"_blank\">website<\/a>. A replay of the webcasts will be available for 90 days following the event.<\/p>\n<p>\n        <strong>About Apellis<\/strong>\u00a0<br \/>Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. Leaders in complement, we ushered in the first new class of complement medicine in 15 years with the approval of the first and only targeted C3 therapy. We are advancing this science to continually develop transformative medicines for people living with rare, retinal, and neurological diseases. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZyvUF9r8eoOtAzJruPshmncK02X30syeUdoya3RzzYgXnSJHIbLaLqNV1WcsAmClUqdJHjFf8_5-bxSGD64enIpg1xuzxxLbsoHnD-nE1vCZ7cYRTe5x3rfHwdSguTjApisQQUU-IJCSwYhoKcIfz-bkg_JfmHecRIaEYlUiVhNWwZBk-7FPJCnl3PLh9ZxJb4G-7aWUlp0LnT7S_9U3KUrK33q6h6lO_U2V3mouzJQW39T4ZScSXLipV154RkYiE_UoQTO0HLI5e4_c1FeDuTigAsuTy1epCVdH_slCSxjSR5G4zMqwaS5Z8Y-ygughktSYFBoBJrnabArBnHAYf4u6K9bQVUkAb3xkM0OF3O03vNJDxZ-QJdhENsv2E2TpunoUfQXcTUTOTJBJFyJThZxWpkZ-MuV6y4l5yiDEFvA=\" rel=\"nofollow noopener\" target=\"_blank\">http:\/\/apellis.com<\/a>\u00a0or follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mJlpFbGi1d-rkmW2aWe9s1H6vzWAPgfHpstVDZcUXR_gxfAQ8rANaRAfJJpJcVoBe-BzY7VtH7pNBUxxSOkJqzgCLCNYjvpBcn5XpfXt5jh1lUBLsOVwCkfDmEU5Bw572SqqAPJgjoRFpqzgOyICmKEualT_DHLwQsPqBBZTO7QYBufpCvdqsdGv8YaBkoHhRuxR6s5t68gjs7n0rZAlJe_7K7KtKBi0JTLrCg_L-uT22kPn_EQKs-yFYE6VJIHRhrjcwovEouj6aNvE_i6CTFW8pBIMiZzFj1U2zT6t22tRCbNhS4wffTrHK3a8nYKuzraELbuLliSVvBJkY537Aw==\" rel=\"nofollow noopener\" target=\"_blank\">Twitter<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qKvhtD0J2hp0JjdaRJZWkYU6_bQCRMc-CsezrMJv9IrFmy4hisVdO3eyhJJ1dwJ-ZjRtwRg3R70Y850wOxXFJgFyTMw1z2cCVR08BydsclZw-pssmRzY6mwSJtQ1Y1K6D59yobCNDZqnz-3xiuzQ1rh4q5QSCP8AW-qWj12h7ga4X9zbE02orPQ15q4zIxya-GOBOvhm3jhM404qQnEo_6dygWtTS3Px4eiBaViybRnRO05fMjA93u100RjbFwJx\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Meredith Kaya<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=g4DNFXHwGt69b3nou3B_dGfOZ9CqvfVBtKnyoIwaqpFgpqPBApi20s-JVwl24tSu_W9ealtVCpZpgZ14xKZw2RCPYK-0tj6Fr8A8cFYPqRGaDEMJabkgRnHegWcxhI9ZH1dsB-Z5E33sE6NgJKuG19-Qs9OGk47WQIzgeogjkL68seGx7SJ0nZFMcxGefAPTch0cPRx_8rlIrZwXMYosqRYnXz9uIzHctA6VPG3Wm50Tr2DE4PjEfEIMSyk30BHiPYXiIIRDsnwaKMVlzE1Iuw==\" rel=\"nofollow noopener\" target=\"_blank\">meredith.kaya@apellis.com<\/a><br \/>617.599.8178<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwMjExNiM1Mjc3MTg2IzIwMjAwMjY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MjliZWRkNGYtNTJlMC00YTgzLWI5ZTYtNmE1MTUxNTQ5ZWM4LTEwMzE1OTg=\/tiny\/Apellis-Pharmaceuticals-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WALTHAM, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) &#8212; \u00a0Apellis Pharmaceuticals,\u00a0Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company will participate in the following investor conferences: 5 th Annual Evercore ISI HealthCONx Conference: Fireside chat on Tuesday, November 29, 2022, at 8:25 a.m. ET. Bank of America 2022 Virtual Biotech SMID Cap Conference: Fireside chat on Wednesday, December 7, 2022, at 9:40 a.m. ET. Each conference event will be available via a live webcast from the \u201cEvents and Presentations\u201d page of the \u201cInvestors and Media\u201d section of the company\u2019s\u00a0website. A replay of the webcasts will be available for 90 days following the event. About Apellis\u00a0Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Apellis Pharmaceuticals to Present at Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-714440","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Apellis Pharmaceuticals to Present at Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Apellis Pharmaceuticals to Present at Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WALTHAM, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) &#8212; \u00a0Apellis Pharmaceuticals,\u00a0Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company will participate in the following investor conferences: 5 th Annual Evercore ISI HealthCONx Conference: Fireside chat on Tuesday, November 29, 2022, at 8:25 a.m. ET. Bank of America 2022 Virtual Biotech SMID Cap Conference: Fireside chat on Wednesday, December 7, 2022, at 9:40 a.m. ET. Each conference event will be available via a live webcast from the \u201cEvents and Presentations\u201d page of the \u201cInvestors and Media\u201d section of the company\u2019s\u00a0website. A replay of the webcasts will be available for 90 days following the event. About Apellis\u00a0Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is &hellip; Continue reading &quot;Apellis Pharmaceuticals to Present at Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-22T21:38:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwMjExNiM1Mjc3MTg2IzIwMjAwMjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Apellis Pharmaceuticals to Present at Upcoming Investor Conferences\",\"datePublished\":\"2022-11-22T21:38:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\\\/\"},\"wordCount\":203,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODcwMjExNiM1Mjc3MTg2IzIwMjAwMjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\\\/\",\"name\":\"Apellis Pharmaceuticals to Present at Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODcwMjExNiM1Mjc3MTg2IzIwMjAwMjY=\",\"datePublished\":\"2022-11-22T21:38:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODcwMjExNiM1Mjc3MTg2IzIwMjAwMjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODcwMjExNiM1Mjc3MTg2IzIwMjAwMjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Apellis Pharmaceuticals to Present at Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Apellis Pharmaceuticals to Present at Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\/","og_locale":"en_US","og_type":"article","og_title":"Apellis Pharmaceuticals to Present at Upcoming Investor Conferences - Market Newsdesk","og_description":"WALTHAM, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) &#8212; \u00a0Apellis Pharmaceuticals,\u00a0Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company will participate in the following investor conferences: 5 th Annual Evercore ISI HealthCONx Conference: Fireside chat on Tuesday, November 29, 2022, at 8:25 a.m. ET. Bank of America 2022 Virtual Biotech SMID Cap Conference: Fireside chat on Wednesday, December 7, 2022, at 9:40 a.m. ET. Each conference event will be available via a live webcast from the \u201cEvents and Presentations\u201d page of the \u201cInvestors and Media\u201d section of the company\u2019s\u00a0website. A replay of the webcasts will be available for 90 days following the event. About Apellis\u00a0Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is &hellip; Continue reading \"Apellis Pharmaceuticals to Present at Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\/","og_site_name":"Market Newsdesk","article_published_time":"2022-11-22T21:38:21+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwMjExNiM1Mjc3MTg2IzIwMjAwMjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Apellis Pharmaceuticals to Present at Upcoming Investor Conferences","datePublished":"2022-11-22T21:38:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\/"},"wordCount":203,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwMjExNiM1Mjc3MTg2IzIwMjAwMjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\/","name":"Apellis Pharmaceuticals to Present at Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwMjExNiM1Mjc3MTg2IzIwMjAwMjY=","datePublished":"2022-11-22T21:38:21+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwMjExNiM1Mjc3MTg2IzIwMjAwMjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwMjExNiM1Mjc3MTg2IzIwMjAwMjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-upcoming-investor-conferences-6\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Apellis Pharmaceuticals to Present at Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/714440","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=714440"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/714440\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=714440"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=714440"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=714440"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}